Most Recent Articles
New Hot Topic — The Region 4 Stork (R4S) Collaborative Project, Part 3: Post-Analytical Interpretive Tools
In Part 3 of this six-part presentation, Piero Rinaldo, M.D., Ph.D., explains how to use the post-analytical interpretive tools in newborn screening.
Read More
Peer-reviewed articles — Week of June 17
Each Monday a list of the latest peer-reviewed articles by members of Mayo Clinic’s Department of Laboratory Medicine and Pathology will be published here. This week there are four articles posted. Read more for links to the abstracts.
Read More
Mayo Laboratory Inquiry receives awards from Contact Center World
Mayo Laboratory Inquiry (MLI), the customer service center for Mayo Medical Laboratories, recently received silver in the Best in Customer Service Award and honorable mention in the Best Contact Center award from Contact Center World. Contact Center World is the leading global support organization and association for the contact center industry around the world.
Read More
Jeffrey Winters, M.D., receives the Lecturer Award from American Society for Apheresis
Jeffrey Winters, M.D., was presented with the American Society for Aphersis’ (ASFA) Lecturer Award at the ASFA Annual Business Meeting Luncheon on May 24. The Lecturer Award of the American Society for Apheresis is bestowed upon a member of the Society who has consistently contributed to the Society as a speaker, teacher, or mentor.
Read More
New Hot Topic: HLA-B*5801 Testing for Allopurinol Severe Cutaneous Adverse Reactions
Allopurinol is a widely used treatment for hyperuricemia-related diseases, but the drug carries the risk of severe adverse cutaneous drug reactions including Stevens Johnson syndrome and toxic epidermal necrolysis, which are considered medical emergencies as they can result in fatalities. This hypersensitivity reaction to allopurinol has been linked to the HLA-B*5801 allele, which is present in both susceptible and healthy individuals at frequencies that vary by ethnicity. Pretreatment testing for HLA-B*5801, in either blood or saliva, can help identity those at risk for these complications.
Read More
Call for abstracts for Individualizing Medicine 2013: From Promise to Practice
Abstracts are due by Friday, June 14, for presentation at Mayo Clinic’s Individualizing Medicine 2013 conference. An online module to submit abstracts is available on the conference abstracts page. Both researchers and providers are encouraged to submit abstracts and case studies. Individualizing Medicine 2013 is scheduled for Sept. 30–Oct. 2 at the Mayo Civic Center and focuses on translation and implementation of genomic medicine in clinical care.
Read More
|